SAN JOSE, Calif. (Reuters) -A U.S. prosecutor told jurors on Thursday that if Theranos founder Elizabeth Holmes had been truthful with investors and patients about her blood-testing startup, the venture never would have attracted critical funding and revenue.
"She chose fraud over business failure. She chose to be dishonest," Assistant U.S. Attorney Jeff Schenk told jurors at the start of closing arguments. "That choice was not only callous, it was criminal."
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
